These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9352624)

  • 1. Serum secretory leukoprotease inhibitor levels in chronic bronchitis and Sjögren's syndrome.
    Andoh Y; Shimura S; Saitoh H; Sasaki T; Mitsuhashi H; Shirato K
    Tohoku J Exp Med; 1997 Aug; 182(4):319-25. PubMed ID: 9352624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum concentrations of secretory leukoprotease inhibitor in patients with primary Sjögren's syndrome.
    Maruyama M; Sugiyama E; Hori T; Murayama R; Nakazaki S; Yamashita N; Kobayashi M
    In Vivo; 1998; 12(5):535-8. PubMed ID: 9827363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometric analysis of airways in Sjögren's syndrome.
    Andoh Y; Shimura S; Sawai T; Sasaki H; Takishima T; Shirato K
    Am Rev Respir Dis; 1993 Nov; 148(5):1358-62. PubMed ID: 8239176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.
    Shugars DC; Watkins CA; Cowen HJ
    Gerontology; 2001; 47(5):246-53. PubMed ID: 11490143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of secretory leukoprotease inhibitor in the human nasal airway.
    Lee CH; Igarashi Y; Hohman RJ; Kaulbach H; White MV; Kaliner MA
    Am Rev Respir Dis; 1993 Mar; 147(3):710-6. PubMed ID: 8095126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical study on secretory leukoprotease inhibitor (SLPI) in sera of patients with various pulmonary diseases].
    Sugimoto H; Hashimoto N; Ameshima S; Gejyo F; Ishizaki T; Miyabo S
    Rinsho Byori; 1995 Dec; 43(12):1267-72. PubMed ID: 8569039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia.
    Grobmyer SR; Barie PS; Nathan CF; Fuortes M; Lin E; Lowry SF; Wright CD; Weyant MJ; Hydo L; Reeves F; Shiloh MU; Ding A
    Crit Care Med; 2000 May; 28(5):1276-82. PubMed ID: 10834665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.
    Hill AT; Bayley D; Stockley RA
    Am J Respir Crit Care Med; 1999 Sep; 160(3):893-8. PubMed ID: 10471615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum secretory leukoprotease inhibitor levels to diagnose pneumonia in the elderly.
    Kida K; Mizuuchi T; Takeyama K; Hiratsuka T; Jinno S; Hosoda K; Imaizumi A; Suzuki Y
    Am Rev Respir Dis; 1992 Dec; 146(6):1426-9. PubMed ID: 1360778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma.
    Ameshima S; Ishizaki T; Demura Y; Imamura Y; Miyamori I; Mitsuhashi H
    Cancer; 2000 Oct; 89(7):1448-56. PubMed ID: 11013357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis.
    Woolhouse IS; Bayley DL; Stockley RA
    Thorax; 2002 Aug; 57(8):667-71. PubMed ID: 12149524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.
    Krejsek J; Slezák R; Kopecky O; Derner V; Andrys C
    Clin Rheumatol; 1997 Mar; 16(2):149-53. PubMed ID: 9093796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
    Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
    Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elimination of secretory leukocyte protease inhibitor (SLPI) from the gastrointestinal tract in man.
    Nyström M; Bergenfeldt M; Ohlsson K
    Scand J Clin Lab Invest; 1997 Apr; 57(2):119-25. PubMed ID: 9200270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of saliva as a diagnostic fluid in Sjögren's syndrome.
    Vissink A; Panders AK; Nauta JM; Ligeon EE; Nikkels PG; Kallenberg CG
    Ann N Y Acad Sci; 1993 Sep; 694():325-9. PubMed ID: 8215079
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation.
    Westin U; Polling A; Ljungkrantz I; Ohlsson K
    Biol Chem; 1999 Apr; 380(4):489-93. PubMed ID: 10355635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel secretory leukocyte protease inhibitor-binding protein involved in membrane phospholipid movement.
    Tseng CC; Tseng CP
    FEBS Lett; 2000 Jun; 475(3):232-6. PubMed ID: 10869562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum level of IL-6 in patients with primary and secondary Sjögren's syndrome.
    Slezák R; Krejsek J; Kopecký O; Jelenová H
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(2):59-60. PubMed ID: 8584859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.
    Gompertz S; Bayley DL; Hill SL; Stockley RA
    Thorax; 2001 Jan; 56(1):36-41. PubMed ID: 11120902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
    Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
    Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.